Global Next Generation Sequencing Market -Market Size, Share & Industry Trends, Growth Analysis Report by Product Type, By Consumption and Forecast 2021 – 2031
Global Next Generation Sequencing Market by Technology (Target Sequencing & Resequencing), Application (Oncology, Consumer Genomics), and Regions, The Asia Pacific, Middle East Africa, Europe, North America, and Latin America) - Global Industry Analysis, Share, Growth, Trends, Size, and Forecast 2021 – 2031
The Next Generation Sequencing market size was valued at USD 4.8 billion in 2021 and is expected to surpass USD XX billion by 2031, expanding at a CAGR of 12.5 % during the forecast period, 2021–2031. The market's growth is attributed to the growing technological developments in NGS instruments.
INTRODUCTION
Next Generation Sequencing refers to DNA sequencing methods and results in genomic discovery. The advantages of next-generation sequencing (NGS) are rapid and accurate sample analysis, cost-effectiveness, and technological advancements. The development of genomics programs in a number of countries is expected to benefit the market.
Market Trends, Drivers, Restraints, and Opportunities
Scope of the Report
Attributes |
Details |
---|---|
Report Title | Next Generation Sequencing Market - Global Industry Analysis, Share, Growth, Trends, Size, and Forecast |
Base Year | 2021 |
Historic Data | 2020–2021 |
Forecast Period | 2021–2031 |
Segmentation | Technology (Target Sequencing & Resequencing), Application (Oncology, Consumer Genomics) |
Regional Scope | The Asia Pacific, Middle East Africa, Europe, North America, and Latin America |
Report Coverage | Market Analysis Company Share & Size, Growth Factors, Trends, Competitive Landscape, Trends, and Revenue Forecast |
Key Players Covered in the Report | QIAGEN N.V. (Netherlands); Thermo Fisher Scientific, Inc. (U.S.); Oxford Nanopore Technologies (U.K.); Genomatix GmbH (U.S.); Perkin Elmer, Inc. (U.S.); Eurofins GATC Biotech GmbH (Germany) |
Market Segment Insights
The targeted sequencing & resequencing segment is projected to register a considerable CAGR
Based on technology, the next generation sequencing market is divided into target sequencing & resequencing. The target sequencing & resequencing segment is expected to expand at a rapid pace during the forecast period owing to the availability of a large amount of whole genome data.
The Oncology segment is expected to expand at a rapid pace
Based on application, the next-generation sequencing market is divided into oncology, and consumer genomics. The oncology segment is expected to expand at a rapid pace during the forecast period owing to the growing prevalence of cancer warrants the use of the latest technology to enable the application of NGS, RNA, and DNA. However, the consumer genomics segment is anticipated to hold a key share of the market in the coming years owing to the continuous introduction of new products by the key players.
The North American region is anticipated to constitute a key market share
In terms of regions, the next-generation sequencing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of the North American region is expected to constitute a key share of the market during the projected period owing to the presence of multiple clinical laboratories that employ NGS to provide genetic testing services. However, the market of the Asia pacific is anticipated to expand at a rapid pace during the forecast period due to the presence of significant developments for technological integration of NGS methodologies and the development of healthcare, clinical development framework of emerging economies, and R & D.
Competitive Landscape
Key players competing in the Next Generation Sequencing market are QIAGEN N.V. (Netherlands); Thermo Fisher Scientific, Inc. (U.S.); Oxford Nanopore Technologies (U.K.); Genomatix GmbH (U.S.); Perkin Elmer, Inc. (U.S.); Eurofins GATC Biotech GmbH (Germany).
FAQs
Mention the market size of the Next Generation Sequencing in 2021.
The market size of Next Generation Sequencing in 2021 was USD 4.8 billion.
During the forecast period, what is the CAGR of the market?
During the forecast period, the CAGR of the market is expected to be 12.5%.
What are the key drivers of the market?
The market's growth is attributed to the growing technological developments in NGS instruments.
What segments are covered in the Next Generation Sequencing report?
The segments covered in the report are technology (target sequencing & resequencing), and application (oncology, consumer genomics).
Mention which region is expected to hold the highest share of the Next Generation Sequencing market.
The North American region is expected to hold the highest share of the Next Generation Sequencing market.
Which segment holds the largest market share in Next Generation Sequencing by 2031?
The oncology segment holds the largest market share in Next Generation Sequencing by 2031.
Mention the key players in the market.
QIAGEN N.V. (Netherlands); Thermo Fisher Scientific, Inc. (U.S.); Oxford Nanopore Technologies (U.K.); Genomatix GmbH (U.S.); Perkin Elmer, Inc. (U.S.); Eurofins GATC Biotech GmbH (Germany).
1 INTRODUCTION TO GLOBAL NEXT GENERATION SEQUENCING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF WISH TREE INSIGHTS
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NEXT GENERATION SEQUENCING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Value Chain Analysis
5 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
5.1 Overview
5.2 Target Sequencing & Resequencing
6 GLOBAL NEXT GENERATION SEQUENCING MARKET, APPLICATION
6.1 Overview
6.2 Oncology
6.3 Consumer Genomics
7 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 The Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Rest of the World
7.5.1 Latin America
7.5.2 The Middle East & Africa
8 GLOBAL NEXT GENERATION SEQUENCING MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
9 COMPANY PROFILES
9.1 QIAGEN N.V. (Netherlands)
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Thermo Fisher Scientific, Inc. (U.S.)
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Oxford Nanopore Technologies (U.K.)
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Genomatix GmbH (U.S.)
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Perkin Elmer, Inc. (U.S.)
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Eurofins GATC Biotech GmbH (Germany)
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
10 Appendix
10.1 Related Research
Segments Covered in the Report
Technology
Application
Regions
Key Players
WishTree Insights uses recent research tools and provides accurate data to the clients. Our expert team delivers the perfect research report that generates revenue and recommendations.
By using the Bottom-Up and Top-Down methods we carry out extensive research. Our focus is on the following parameters:
Our expertise uses primary research with Key for validating the market forecasts:
WishTree Database
Primary research |
Secondary research |
---|---|
|
|
|
|
|
|
|
|
|
Industry Analysis
Qualitative analysis |
Quantitative analysis |
---|---|
|
|
|
|
|
|
|
|
|
|
|
Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization